Medical Properties Trust Stock Current Liabilities
M3P Stock | 4.00 0.08 2.04% |
Medical Properties Trust fundamentals help investors to digest information that contributes to Medical Properties' financial success or failures. It also enables traders to predict the movement of Medical Stock. The fundamental analysis module provides a way to measure Medical Properties' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medical Properties stock.
Medical |
Medical Properties Trust Company Current Liabilities Analysis
Medical Properties' Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
Competition |
In accordance with the recently published financial statements, Medical Properties Trust has a Current Liabilities of 0.0. This indicator is about the same for the Other average (which is currently at 0.0) sector and about the same as Other (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
Did you try this?
Run Money Managers Now
Money ManagersScreen money managers from public funds and ETFs managed around the world |
All Next | Launch Module |
Medical Fundamentals
Current Valuation | 15.57 B | |||
Price To Book | 0.80 X | |||
Price To Sales | 4.52 X | |||
EBITDA | 1.34 B | |||
Net Income | 902.6 M | |||
Total Debt | 10.27 B | |||
Cash Flow From Operations | 811.66 M | |||
Market Capitalization | 11.53 B | |||
Total Asset | 19.66 B | |||
Z Score | 0.6 | |||
Annual Yield | 0.05 % | |||
Net Asset | 19.66 B |
About Medical Properties Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medical Properties Trust's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medical Properties using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medical Properties Trust based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Medical Stock Analysis
When running Medical Properties' price analysis, check to measure Medical Properties' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medical Properties is operating at the current time. Most of Medical Properties' value examination focuses on studying past and present price action to predict the probability of Medical Properties' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medical Properties' price. Additionally, you may evaluate how the addition of Medical Properties to your portfolios can decrease your overall portfolio volatility.